This inventor holds 1 USPTO granted patent. Top assignee: Katholieke Universiteit Leuven. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Peter Sinnaeve
Introduction
Peter Sinnaeve is a notable inventor based in Blanden, Belgium. He has made significant contributions to the field of cardiovascular disease research. His work focuses on the diagnosis and prognosis of cardiovascular events, which is crucial for improving patient outcomes.
Latest Patents
Peter Sinnaeve holds a patent related to oxidative stress and cardiovascular disease events. The invention pertains to the diagnosis and/or prognosis of cardiovascular disease and cardiovascular events. A prognostic risk score can be determined by counting the number of deregulated genes in isolated monocytes. Deregulation is defined by low expression of COX1, COX4I1, TFAM, and RUNX2. This innovative approach has the potential to enhance the understanding of cardiovascular health.
Career Highlights
Peter Sinnaeve is affiliated with Katholieke Universiteit Leuven, where he conducts research and develops his inventions. His work has garnered attention for its relevance in the medical field, particularly in understanding cardiovascular diseases.
Collaborations
Peter has collaborated with esteemed colleagues such as Paul N Holvoet and Stefan Janssens. These partnerships have contributed to the advancement of research in cardiovascular health.
Conclusion
Peter Sinnaeve's contributions to the field of cardiovascular disease through his innovative patent highlight the importance of research in improving health outcomes. His work continues to influence the understanding of cardiovascular events and their underlying mechanisms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile